BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25869443)

  • 1. [Assessment of patients' knowledge of first-trimester combined Down syndrome screening at the time of their first trimester ultrasonographic evaluation: Results of a prospective study about 201 women].
    de Villardi de Montlaur D; Desseauve D; Marechaud M; Pierre F
    J Gynecol Obstet Biol Reprod (Paris); 2016 Jan; 45(1):62-70. PubMed ID: 25869443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What about informed consent in first-trimester ultrasound screening for Down syndrome?
    Favre R; Moutel G; Duchange N; Vayssière C; Kohler M; Bouffet N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Nisand I
    Fetal Diagn Ther; 2008; 23(3):173-84. PubMed ID: 18417975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First trimester screening for Down syndrome at Prima facie. A 6-year survey].
    Roth P; Bernard JP; Meyer V; Beaujard MP; Salomon LJ; Ville Y
    Gynecol Obstet Fertil; 2016 Feb; 44(2):101-5. PubMed ID: 26725884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester Down syndrome screening: pregnant women's knowledge.
    Dahl K; Hvidman L; Jørgensen FS; Henriques C; Olesen F; Kjaergaard H; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingent screening for Down syndrome completed in the first trimester: a multicenter study.
    Muñoz-Cortes M; Arigita M; Falguera G; Seres A; Guix D; Baldrich E; Acera A; Torrent A; Rodriguez-Veret A; Lopez-Quesada E; Garcia-Moreno R; Gonce A; Borobio V; Borrell A
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):396-400. PubMed ID: 21674658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the non-respect of ethical principles by health professionals during first-trimester sonographic Down syndrome screening damaging to patient autonomy?
    Favre R; Guige V; Weingertner AS; Vayssière C; Kohler M; Nisand I; Hervé C; Moutel G
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):25-32. PubMed ID: 19489032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
    Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
    Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of prenatal screening and psychological management of test decisions.
    Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
    Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Womens' preference in Down syndrome screening.
    de Graaf IM; Tijmstra T; Bleker OP; van Lith JM
    Prenat Diagn; 2002 Jul; 22(7):624-9. PubMed ID: 12124700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuchal translucency: this is not so simple!].
    Constant M
    Gynecol Obstet Fertil; 2014 Dec; 42(12):820-1. PubMed ID: 25456489
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Hum Reprod; 2009 Jan; 24(1):55-62. PubMed ID: 18835870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.